Sommaire

• • ·Table of Contents

    Page :i

    
• • ·Editorial Board

    Page :iv

    
• • ·Information for Readers

    Page :v

    

• Trial Designs

  • ·Comparison of the polymer-free biolimus-coated BioFreedom stent with the thin-strut biodegradable polymer sirolimus-eluting Orsiro stent in an all-comers population treated with percutaneous coronary intervention: Rationale and design of the randomized SORT OUT IX trial

    Page :1-7

    Lisette Okkels Jensen, Michael Maeng, Bent Raungaard, Thomas Engstrøm, Henrik Steen Hansen, Svend Eggert Jensen, Hans Erik Bøtker, Johnny Kahlert, Jens Flensted Lassen, Evald Høj Christiansen

    Résumé Résumé Plan Plan  
  • ·Fractional flow reserve guided percutaneous coronary intervention optimization directed by high-definition intravascular ultrasound versus standard of care: Rationale and study design of the prospective randomized FFR-REACT trial

    Page :66-72

    Laurens J.C. van Zandvoort, Kaneshka Masdjedi, Maria Natalia Tovar Forero, Mattie J. Lenzen, Jurgen Ligthart, Roberto Diletti, Miguel E. Lemmert, Jeroen Wilschut, Peter P.T. de Jaegere, Felix Zijlstra, Nicolas M. van Mieghem, Joost Daemen

    Résumé Résumé Plan Plan  
  • ·Rivaroxaban, a direct Factor Xa inhibitor, versus acetylsalicylic acid as thromboprophylaxis in children post–Fontan procedure: Rationale and design of a prospective, randomized trial (the UNIVERSE study)

    Page :97-104

    Liza Miriam Pina, Xiangwen Dong, Liping Zhang, Mahesh N. Samtani, Alan D. Michelson, Henri Justino, Damien Bonnet, Kevin C. Harris, John Jefferies, Brian W. McCrindle, Jennifer S. Li

    Résumé Résumé Plan Plan  

• Clinical Investigations

  • ·Right ventricular function in patients with pulmonary regurgitation with versus without tetralogy of Fallot

    Page :8-17

    Guillermo Larios, Deane Yim, Andreea Dragulescu, Luc Mertens, Lars Grosse-Wortmann, Mark K. Friedberg

    Résumé Résumé Plan Plan  
  • ·Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF

    Page :35-46

    Sylvia Haas, A John Camm, Jean-Pierre Bassand, Pantep Angchaisuksiri, Frank Cools, Ramon Corbalan, Harry Gibbs, Barry Jacobson, Yukihiro Koretsune, Lorenzo G Mantovani, Frank Misselwitz, Elizaveta Panchenko, Hany Ibrahim Ragy, Janina Stepinska, Alexander GG Turpie, Jitendra PS Sawhney, Jan Steffel, Toon Wei Lim, Karen S Pieper, Saverio Virdone, Freek WA Verheugt, Ajay K Kakkar, for the GARFIELD-AF Investigators 1

    Résumé Résumé Plan Plan   
  • ·Risk of obstructive coronary artery disease and major adverse cardiac events in patients with noncoronary atherosclerosis: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) Program

    Page :47-56

    J. Antonio Gutierrez, Deepak L. Bhatt, Subhash Banerjee, Thomas J. Glorioso, Kevin P. Josey, Rajesh V. Swaminathan, Thomas M. Maddox, Ehrin J. Armstrong, Claire Duvernoy, Stephen W. Waldo, Sunil V. Rao

    Résumé Résumé Plan Plan   
  • ·Ticagrelor in patients with heart failure after acute coronary syndromes—Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial

    Page :57-65

    Axel Åkerblom, Daniel M. Wojdyla, Lars Wallentin, Stefan K. James, Flávio de Souza Brito, Philippe Gabriel Steg, Christopher P. Cannon, Hugo A. Katus, Anders Himmelmann, Robert F. Storey, Richard C. Becker, Renato D. Lopes, on behalf of the PLATO Investigators

    Résumé Résumé Plan Plan  
  • ·Factors for modifying the termination of resuscitation rule in out-of-hospital cardiac arrest

    Page :73-80

    Jae Chol Yoon, Youn-Jung Kim, Shin Ahn, Young-Ho Jin, Sung-Woo Lee, Kyoung Jun Song, Sang Do Shin, Sung Oh Hwang, Won Young Kim, on behalf of the Korean Cardiac Arrest Research Consortium KoCARC

    Résumé Résumé Plan Plan   
  • ·Smoking cessation and risk of recurrent cardiovascular events and mortality after a first manifestation of arterial disease

    Page :112-122

    M. Johanneke van den Berg, Yolanda van der Graaf, Jaap W. Deckers, Wanda de Kanter, Ale Algra, L. Jaap Kappelle, Gert J. de Borst, Maarten-Jan M. Cramer, Frank L.J. Visseren, on behalf of the SMART study group

    Résumé Résumé Plan Plan   

• Research Letters

  • ·Increased hepatocyte growth factor levels over 2 years are associated with coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA)

    Page :30-34

    Paul A. Decker, Nicholas B. Larson, Elizabeth J. Bell, James S. Pankow, Naomi Q. Hanson, Christina L. Wassel, Michael Y. Tsai, Suzette J. Bielinski

    Résumé Résumé Plan Plan  
  • ·Response to the letter to the editor regarding the results of the retrospective study “Predictors of intra-aortic balloon pump hemodynamic failure in non-acute myocardial infarction cardiogenic shock” published in the American Heart Journal

    Page :124-125

    Steven Hsu

     

• Clinical Investigations

  • ·Cardiogenic shock during heart failure hospitalizations: Age-, sex-, and race-stratified trends in incidence and outcomes

    Page :18-29

    Srikanth Yandrapalli, Abdallah Sanaani, Prakash Harikrishnan, Wilbert S. Aronow, William H. Frishman, Gregg M. Lanier, Ali Ahmed, Gregg C. Fonarow

    Résumé Résumé Plan Plan   
  • ·Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation II

    Page :81-90

    Taku Inohara, Peter Shrader, Karen Pieper, Rosalia G. Blanco, Larry A. Allen, Gregg C. Fonarow, Bernard J. Gersh, Alan S. Go, Michael D. Ezekowitz, Peter R. Kowey, James A. Reiffel, Gerald V. Naccarelli, Paul S. Chan, Kenneth W. Mahaffey, Daniel E. Singer, James V. Freeman, Benjamin A. Steinberg, Eric D. Peterson, Jonathan P. Piccini, ORBIT AF Patients and Investigators

    Résumé Résumé Plan Plan   
  • ·Comorbidities and the decision to undergo or forego destination therapy left ventricular assist device implantation: An analysis from the Trial of a Shared Decision Support Intervention for Patients and their Caregivers Offered Destination Therapy for End-Stage Heart Failure (DECIDE-LVAD) study

    Page :91-96

    Haider J. Warraich, Larry A. Allen, Laura J. Blue, Erin L. Chaussee, Jocelyn S. Thompson, Colleen K. McIlvennan, Kelsey M. Flint, Daniel D. Matlock, Chetan B. Patel

    Résumé Résumé Plan Plan  
  • ·Incidence and predictors of target lesion failure in patients undergoing contemporary DES implantation—Individual patient data pooled analysis from 6 randomized controlled trials

    Page :105-111

    Maayan Konigstein, Mahesh V. Madhavan, Ori Ben-Yehuda, Hussein M. Rahim, Iva Srdanovic, Fotis Gkargkoulas, Ghazaleh Mehdipoor, Evan Shlofmitz, Akiko Maehara, Björn Redfors, Ankita K. Gore, Thomas McAndrew, Gregg W. Stone, Ziad A. Ali

    Résumé Résumé Plan Plan  

• Research Letters

  • ·Letter to the editor regarding the results of the retrospective study “Predictors of intra-aortic balloon pump hemodynamic failure in non-acute myocardial infarction cardiogenic shock” published in the American Heart Journal

    Page :123

    Alice Sacco, Nuccia Morici, Fabrizio Oliva

    

• Erratum

  • ·Corrigendum to “A prospective 5-year study of exercise performance following melody valve implant”, American Heart Journal. 2018 Dec 29; 209:47–53

    Page :126

    B Priromprintr, MJ Silka, J Rhodes, Anjan S Batra